Amyloid precursor protein: a regulatory hub in Alzheimer's disease

J Chen, JS Chen, S Li, F Zhang, J Deng… - Aging and …, 2024 - pmc.ncbi.nlm.nih.gov
Decades of research have demonstrated an incontrovertible role of amyloid-β (Aβ) in the
etiology of Alzheimer's disease (AD). However, the overemphasis on the pathological …

Retromer Proteins Reduced in Down Syndrome and the Dp16 Model: Impact of APP Dose and Preclinical Studies of a γ‐Secretase Modulator

XQ Chen, M Sawa, A Becker… - Annals of …, 2023 - Wiley Online Library
Objective The retromer complex plays an essential role in intracellular endosomal sorting.
Deficits in the retromer complex are linked to enhanced Aβ production. The levels of the …

γ‐Secretase Modulator BPN15606 Reduced Aβ42 and Aβ40 and Countered Alzheimer‐Related Pathologies in a Mouse Model of Down Syndrome

XQ Chen, A Becker, R Albay, PD Nguyen… - Annals of …, 2024 - Wiley Online Library
Objectives Due to increased gene dose for the amyloid precursor protein (APP), elderly
adults with Down syndrome (DS) are at a markedly increased risk of Alzheimer's disease …

Integration of ATAC-seq and RNA-seq identifies MX1-mediated AP-1 transcriptional regulation as a therapeutic target for Down syndrome

Z Guo, Y Zhu, H **ao, R Dai, W Yang, W Xue… - Biological Research, 2023 - Springer
Background Growing evidence has suggested that Type I Interferon (I-IFN) plays a potential
role in the pathogenesis of Down Syndrome (DS). This work investigates the underlying …

Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease

L **e, Y Raj, P Varathan, B He, M Yu… - Journal of …, 2024 - journals.sagepub.com
Background: There are various molecular hypotheses regarding Alzheimer's disease (AD)
like amyloid deposition, tau propagation, neuroinflammation, and synaptic dysfunction …

Synaptic dysfunction in Down syndrome: an emerging role for circulating β2-microglobulin

XQ Chen - Signal Transduction and Targeted Therapy, 2023 - nature.com
Recent research by Gao et al. published in Cell proposes that circulating β2-microglobulin
impairs synaptic function through antagonizing NMDA receptors in two mouse models of …

[HTML][HTML] New insights into the effects of APP gene dose on synapse in Down syndrome

XQ Chen, X Zuo - Neural Regeneration Research, 2024 - journals.lww.com
Synaptic dysfunction: Alzheimer's disease (AD) is a prevalent form of dementia, affecting
over 35 million people worldwide (Tzioras et al., 2023). A synapse serves as the connection …

Impact of Cre/LoxP-Mediated Chromosome Engineering Technology on Down Syndrome Research

Z **ng, A Douglas, A Pao, T Glass, N Connor… - Genetic Models of Down …, 2025 - Springer
Abstract Down syndrome (DS; trisomy 21) significantly impacts the human population,
affecting up to six million people, and understanding the underlying mechanisms is crucial …

Unraveling the Multi-omic Network and Pathway Alterations in Alzheimer's Disease

L **e - 2024 - hammer.purdue.edu
Multi-omic studies ranging from genomics, transcriptomics (eg, gene expression) to
proteomics data exploration have been widely applied to interpret findings from genome …

Exploring Alzheimer's disease and Down syndrome neuro-immune pathways using preclinical models and human post-mortem brain tissue

C Farrell - 2024 - discovery.ucl.ac.uk
Down syndrome (DS), caused by trisomy of chromosome 21 (Hsa21), causes the
development of Alzheimer's disease (AD), due to people with DS having three-copies of the …